Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

November 22, 2006 06:00 ET

Meridian Co. Ltd. to Be Broadcast on Green Baron Webcast to 700,000 Members, Monday, November 27, 2006

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Nov. 22, 2006) - Meridian Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), an industry leader in the research/development, manufacturing and sales of integrative medical equipment, is pleased to announce that representatives from Meridian Medical Inc. ("MMI"), Meridian's North American Corporate and Distribution office will conduct a joint webcast with The Green Baron. This will provide an opportunity for Meridian to inform its shareholders and the investment community about the exciting developments currently taking place.

MMI will represent Meridian on this webcast to provide further information on many new developments in North America. This will include progress updates to the recently announced US$28,000,000 Letter of Intent to supply the Digital Pulse Analyzer to a subcontractor under a US federal government contract.

Anna Brazier, Managing Director of MMI and Scott Lee, the Korean Corporate Liaison of MMI, will lead the webcast with Green Baron. Anna Brazier stated, "There are so many new developments unfolding right now that we felt the necessity to inform the investment community in as timely a manner as possible."

The webcast will be hosted by Evergreen Marketing, and conducted by their subsidiary and will be available for listening on Monday, November 27 on The Green Baron Investors Society's website

For more information about Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society visit them on the web at and

The webcast will also be available for listening along with additional information on Meridian Medical, Inc. on's affiliate website

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of integrative medical equipment. The Company sells its products and equipment to a wide range of customers in the global health care industry. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval, as well as other international regulatory approvals, for many of its products.

On Behalf of the Board of Directors, Hyeon Seong Myeong President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information

  • Meridian Co., Ltd.
    Peter Holeczek
    Corporate Communications